Extended Half-Life (EHL) Clotting Factor for Improving the Musculoskeletal Health of Patients With Hemophilia
Clinical trial NCT03914209 · UNKNOWN
Trial details
- NCT number
- NCT03914209
- Sponsor
- Investigación en Hemofilia y Fisioterapia
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-02
- Primary completion
- 2021-09-21
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.